{
  "variants": [
    {
      "gene": "SNCA",
      "protein_change": {
        "ref": "loss_of_function",
        "alt": "loss_of_function",
        "position": "N/A"
      },
      "variant_string_id": "SNCA loss_of_function",
      "context": "Loss of function variants in SNCA are associated with late-onset Parkinson's disease. Functional assay showed 50% reduction in α-synuclein protein levels.",
      "acmg_flowchart": {
        "step_1": {
          "judgment": "Yes",
          "reason": "Disease mechanism is loss of function in SNCA leading to reduced protein levels, associated with Parkinson's disease."
        },
        "step_2": {
          "judgment": "Yes",
          "reason": "Cell-based assay measuring protein levels is applicable to the pathogenesis of Parkinson's disease."
        },
        "step_3": {
          "step_3a": {
            "judgment": "No",
            "reason": "Context does not specify controls or replicates."
          },
          "step_3b": {
            "judgment": "Yes",
            "reason": "Cell-based protein expression assays are standard in the field."
          },
          "step_3c": {
            "judgment": "No",
            "reason": "No controls are mentioned in the context."
          }
        },
        "step_4": {
          "step_4a": {
            "judgment": "No",
            "reason": "Context does not mention statistical significance or analysis."
          },
          "step_4b": {
            "judgment": "Yes",
            "reason": "Assumed ≤10 controls used in the study, leading to PS3_supporting."
          }
        },
        "final_evidence_strength": "PS3_supporting"
      }
    },
    {
      "gene": "LRRK2",
      "protein_change": {
        "ref": "G",
        "alt": "S",
        "position": "2019"
      },
      "variant_string_id": "LRRK2 G2019S",
      "context": "LRRK2 G2019S is a well-characterized variant associated with Parkinson's disease. Functional assay showed increased kinase activity.",
      "acmg_flowchart": {
        "step_1": {
          "judgment": "Yes",
          "reason": "Disease mechanism is gain of function in LRRK2, leading to increased kinase activity, associated with Parkinson's disease."
        },
        "step_2": {
          "judgment": "Yes",
          "reason": "Assays measuring kinase activity are directly relevant to the pathogenesis of Parkinson's disease."
        },
        "step_3": {
          "step_3a": {
            "judgment": "No",
            "reason": "Context does not specify controls or replicates."
          },
          "step_3b": {
            "judgment": "Yes",
            "reason": "Kinase activity assays are standard in the field."
          },
          "step_3c": {
            "judgment": "No",
            "reason": "No controls are mentioned in the context."
          }
        },
        "step_4": {
          "step_4a": {
            "judgment": "No",
            "reason": "Context does not mention statistical significance or analysis."
          },
          "step_4b": {
            "judgment": "Yes",
            "reason": "Assumed ≤10 controls used in the study, leading to PS3_supporting."
          }
        },
        "final_evidence_strength": "PS3_supporting"
      }
    },
    {
      "gene": "PINK1",
      "protein_change": {
        "ref": "c.534_535del",
        "alt": "c.534_535del",
        "position": "N/A"
      },
      "variant_string_id": "PINK1 c.534_535del",
      "context": "PINK1 frameshift variant leads to loss of function and impaired mitochondrial function, associated with Parkinson's disease.",
      "acmg_flowchart": {
        "step_1": {
          "judgment": "Yes",
          "reason": "Disease mechanism is loss of function in PINK1, leading to mitochondrial dysfunction, associated with Parkinson's disease."
        },
        "step_2": {
          "judgment": "Yes",
          "reason": "Cell-based assays measuring mitochondrial function are directly relevant to the pathogenesis of Parkinson's disease."
        },
        "step_3": {
          "step_3a": {
            "judgment": "No",
            "reason": "Context does not specify controls or replicates."
          },
          "step_3b": {
            "judgment": "Yes",
            "reason": "Mitochondrial function assays are standard in the field."
          },
          "step_3c": {
            "judgment": "No",
            "reason": "No controls are mentioned in the context."
          }
        },
        "step_4": {
          "step_4a": {
            "judgment": "No",
            "reason": "Context does not mention statistical significance or analysis."
          },
          "step_4b": {
            "judgment": "Yes",
            "reason": "Assumed ≤10 controls used in the study, leading to PS3_supporting."
          }
        },
        "final_evidence_strength": "PS3_supporting"
      }
    },
    {
      "gene": "APOE",
      "protein_change": {
        "ref": "E",
        "alt": "E",
        "position": "4"
      },
      "variant_string_id": "APOE E4",
      "context": "APOE E4 variant is associated with increased Aβ42 accumulation in Alzheimer's disease. Functional assay showed 40% increase in Aβ42.",
      "acmg_flowchart": {
        "step_1": {
          "judgment": "Yes",
          "reason": "Disease mechanism is increased Aβ42 accumulation in APOE E4, associated with Alzheimer's disease."
        },
        "step_2": {
          "judgment": "Yes",
          "reason": "Assays measuring Aβ42 levels are directly relevant to the pathogenesis of Alzheimer's disease."
        },
        "step_3": {
          "step_3a": {
            "judgment": "No",
            "reason": "Context does not specify controls or replicates."
          },
          "step_3b": {
            "judgment": "Yes",
            "reason": "Aβ42 assays are standard in the field."
          },
          "step_3c": {
            "judgment": "No",
            "reason": "No controls are mentioned in the context."
          }
        },
        "step_4": {
          "step_4a": {
            "judgment": "No",
            "reason": "Context does not mention statistical significance or analysis."
          },
          "step_4b": {
            "judgment": "Yes",
            "reason": "Assumed ≤10 controls used in the study, leading to PS3_supporting."
          }
        },
        "final_evidence_strength": "PS3_supporting"
      }
    },
    {
      "gene": "MAPT",
      "protein_change": {
        "ref": "R",
        "alt": "W",
        "position": "406"
      },
      "variant_string_id": "MAPT R406W",
      "context": "MAPT R406W leads to loss of function and altered microtubule dynamics, associated with frontotemporal dementia (FTD).",
      "acmg_flowchart": {
        "step_1": {
          "judgment": "Yes",
          "reason": "Disease mechanism is loss of function in MAPT, leading to microtubule instability, associated with FTD."
        },
        "step_2": {
          "judgment": "Yes",
          "reason": "Cell-based assays measuring microtubule dynamics are directly relevant to the pathogenesis of FTD."
        },
        "step_3": {
          "step_3a": {
            "judgment": "No",
            "reason": "Context does not specify controls or replicates."
          },
          "step_3b": {
            "judgment": "Yes",
            "reason": "Microtubule dynamics assays are standard in the field."
          },
          "step_3c": {
            "judgment": "No",
            "reason": "No controls are mentioned in the context."
          }
        },
        "step_4": {
          "step_4a": {
            "judgment": "No",
            "reason": "Context does not mention statistical significance or analysis."
          },
          "step_4b": {
            "judgment": "Yes",
            "reason": "Assumed ≤10 controls used in the study, leading to PS3_supporting."
          }
        },
        "final_evidence_strength": "PS3_supporting"
      }
    }
  ]
}